ONK Therapeutics

ONK Therapeutics is rated 3 out of 5 in the category biotechnology. Read and write reviews about ONK Therapeutics. ONK Therapeutics was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells. NK cells are one of body’s strongest defences against cancer, being one of the most tumour cytotoxic components of the human immune system. The company’s strategy is to develop novel novel, off the shelf, NK cell-based therapies for cancer. Further, the company is seeking to enhance these NK cells through the introduction of a series of genetic modifications, creating a technology platform that can be tailored to multiple cancers.